Telehealth has been around since the 1960s as a healthcare delivery modality, though it did not gain widespread acceptance as a viable and reliable clinical tool until the late 1990s, when digital imaging and high speed, high bandwidth telecommunications technology became widely available [1]. Historical boundaries to its acceptance and

HIV/AIDS continues to be a major public health disease accounting for 35 million deaths across the world. In 2016 alone, there were 1.8 million new HIV infections and 1 million deaths worldwide.

Despite better treatments and technology available in usual clinical practice, achieving a good glycemic control in patients with diabetes is challenging. In times of SARSCoV- 2/COVID-19 infection, chronic diseases like diabetes have been associated with adverse outcomes.

The term “Primary Dysmenorrhea” may no longer adequately describe a patient’s diagnosis, given the capabilities of modern imaging technology to detect possible deep infiltrating endometriosis. Laparoscopy alone may not be sufficient for diagnosing endometriosis. Considering the availability of specific therapeutic interventions tailored for endometriosis, there is a compelling case for pursuing a more targeted diagnostic approach.

Appendiceal endometriosis (AE) represents a clinically significant yet frequently overlooked manifestation of endometriosis that may contribute to persistent symptoms and suboptimal treatment outcomes. Multiple comprehensive reviews demonstrate that appendiceal involvement occurs in a notable percentage of women with endometriosis and can present with distinctive symptom patterns.